Downregulation of microRNA-542-5 p and its relationship with EGFR and clinicopathological features in hepatocellular carcinoma
Jian-Jun Li,Xia Yang,Xiao-Miao Lin,Rong-Quan He,Xing-Gu Lin,Yi-Huan Luo,Han-Lin Wang,Fei-Fei,Luo,Xin Wen,Yi-Wu Dang,Gang Chen
2016-01-01
Abstract:Aim: To explore the expression of miR-542-5p in Hepatocellular Carcinoma (HCC), and to investigate the relationship between expressions of miR-542-5p and its potential target gene EGFR, as well as the clinical significance of miR-542-5p in HCC. Materials and methods: One hundred and one paraffin-embedded samples from primary surgical resection of HCC with complete clinical data were selected from the First Affiliated Hospital, Guangxi Medical University, China. The expression of miR-542-5p in HCC and adjacent noncancerous tissues was detected by quantitative real-time RT-PCR. Then the relation between patients’ age, tumor grade, TNM stage, lymph node metastasis, recurrent event and miR-542-5p expression was analyzed. The expression of EGFR was detected with immunohistochemistry. Besides, we performed in silico prediction of the complementarity of miR-542-5p sequence to EGFR with Targetscan, miRTar and miRanda, respectively. Results: The expression of miR-542-5p in HCC tissues was 2.3028±1.26610, significantly lower than that in adjacent noncancerous tissues (3.3767±2.58785, P=0.001). The area under curve (AUC) of low miR-542-5p expression to diagnose HCC was 0.603 (95% CI: 0.5240.681, P=0.012) with a cut-off value 1.990 evaluated by the mean expression of miR-542-5p in both HCC and adjacent noncancerous tissues. The expression of miR-542-5p was negatively correlated with tumor nodes number (r=-0.278, P=0.005), clinical TNM stage (r=-0.233, P=0.019), metastasis (r=-0.221, P=0.026), tumor capsular infiltration (r=-0.202, P=0.043), and tumor embolus in portal vein (r=-0.212, P=0.033). A negative correlation was found between the expression levels of EGFR and miR-542-5p (r=-0.139, P=0.049), which was consistent with in silico prediction. Additionally, the recurrent time of lower miR-542-5p expression group was 47.653±2.937 months, slightly shorter than that in the high expression group (63.400±3.095 months), however, no significant difference was noted (Chi-square=3.284, P=0.070). Conclusion: MiR-542-5p may play a vital role in the carcinogenesis and progression of HCC. There possibly exists a complementary targeting relationship between EGFR and miR-542-5p.